Picture of Rallybio logo

RLYB — Rallybio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Brief: Rallybio Presents Natural History Study For Fetal And Neonatal Alloimmune Thrombocytopenia

Dec 9 (Reuters) - Rallybio Corp  RLYB.O :
    * RALLYBIO PRESENTS NATURAL HISTORY STUDY FOR FETAL AND
NEONATAL
ALLOIMMUNE THROMBOCYTOPENIA AT THE 65TH AMERICAN SOCIETY OF
HEMATOLOGY ANNUAL MEETING

Source text for Eikon:  ID:nBw4rB2KLa 
Further company coverage:  RLYB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Rallybio

See all news